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adolescents: Findings from a Cochrane systematic review and meta-analysis 
Abstract 
Introduction:  The evidence that teaching self-management techniques to children and young 
people with asthma in schools is effective has not, to date, been the subject of systematic review.  
Methods:  We conducted a systematic review of intervention studies. Studies were eligible if 
they employed a randomised parallel-group design, and were published in English from 1995 
onwards. Participants included 5-18 year old children with asthma who participated within their 
own school environment. Searches were conducted on the Cochrane Airways Group Specialised 
Register. Quantitative data were combined using random-effects meta-analyses. 
Results: Thirty-three outcome evaluation studies were included. School based interventions 
were effective in reducing the frequency of emergency department visits (OR 0.70, 95% CI 0.53 
to 0.92; studies=13), and moderately effective in reducing levels of hospitalisations (SMD -0.19, 
95% CI -0.35 to -0.04; studies=6). A meta-analysis of three studies suggest that the intervention 
approach could reduce the number of days of restricted activity (SMD -0.30, 95% CI -0.41 to -
0.18; studies=3). However, there was uncertainty as to whether school-based self-management 
interventions impacted on reducing absences from school.  
Conclusions: Self-management interventions for children with asthma delivered in schools 
reduce the number of acute episodes of healthcare usage. We conclude that the school 
environment is an important space for delivering interventions to improve children’s health. 
 
Key messages 
What is the key question? 
 Do schools provide an effective space for teaching children with asthma the self-
management techniques they need in order to lower their levels of healthcare usage, 
improve their asthma symptomology, and lower their levels of school absences?  
What is the bottom line? 
 Meta-analysis of randomised controlled trial data shows that children who receive 
school-based asthma self-management interventions have reduced levels of 
hospitalisations, emergency department visits, and show an improvement in days of 
restricted activity. However, no impact was observed on levels of school absence. 
Why read on? 
 This is the first systematic review and meta-analysis of school-based asthma 
interventions. 
Introduction 
Asthma is the most common chronic non-communicable disease among children 1 and, in 
England, almost one in six children aged 5-14 years will have experienced asthma at some point 
2, with substantial impacts on their health-related quality of life. For example over 2.8 million 
school days per annum are estimated to be lost in the UK due to asthma and asthmatic 
symptoms3. Well-controlled asthma consists of reduced daytime and night-time symptoms, 
decreased long-term morbidity and diminished risk of life-threatening asthma attacks4. Self-
management, a cornerstone of treatment for people with asthma5, is the systematic process of 
educating and enabling individuals to achieve good control of their asthma symptoms, thereby 
preventing future exacerbations6.  
 
Schools are postulated to be effective sites for teaching asthma self-management techniques to 
children due to their familiarity as environments for learning, and the potential for identification 
of large numbers of children with asthma at a single school site7-9. However, few reviews exist 
that have focused explicitly on schools as delivery sites, or have synthesised information across 
studies using meta-analysis. There consequently remains uncertainty as to the impact of 
providing self-management education and support within schools. In this systematic review, we 
therefore aimed to identify and synthesise evidence on school-based self-management 
interventions for children with asthma, with a focus on effectiveness. Although delivery of an 
asthma self-management intervention in schools is a potential way of reducing asthma burden in 
children and young people, to date uncertainty remains as to the effectiveness of this approach 
across a number of different outcomes (10 11).  
 
Methods 
 
Full details of the methods used were published on registration of the protocol for this review 
through the Cochrane Collaboration (CD011651)12 .  The complete review aimed to address two 
key objectives: (i) identify the key design features and processes associated with successful 
implementation of school-based asthma self-management interventions; (ii) understand whether 
school-based interventions can effectively change asthma self-management behaviour. In this 
manuscript, we focus on the quantitative synthesis of evidence on the effectiveness school-based 
asthma interventions. Complete details, including the results of the review of intervention design 
and implementation factors can be found in the full companion Cochrane review, which is 
published simultaneously with this paper11.  
 
Study eligibility 
 
Studies were eligible if they employed a randomised parallel-group design with children 
randomised individually or in clusters, and were published in English from 1995 onwards (this 
date corresponding with publication of the first Global Initiative for Asthma (GINA) guidelines, 
which provided a foundation for asthma guidelines globally13. Participants included school-aged 
(five-year-old to 18-year-old) children and young people with asthma who participated within 
their own school environment.  
 
All included interventions aimed to develop and enhance self-management of asthma among 
children through at least one of the following components: (i) increasing knowledge of asthma 
and its management; (ii) enhancing self-management skills; (iii) improving self-management 
behaviours and practice. The definition of self-management used followed British Thoracic 
Society (BTS) guidelines14 and eligible studies included the development of at least one of the 
following components: reinforcement of regular lung function monitoring; development of an 
therapeutic alliance between patients and healthcare practitioners; instruction on inhaler 
techniques; reinforcement/provision of an individualised written asthma management plan; 
instruction on the appropriate use of reliever and preventer therapies; and selected non-
pharmacological strategies. Thus, an intervention where school nurses directly delivered 
medication to children or directly observed therapy (e.g. Halterman et al15), but which did not 
include a component aimed at developing self-management skills, would be excluded  (see 
supplementary materials). Self-management interventions could either be provided by a trained 
educator, or nurse (including school, practice or community nurse), or doctor or physician, or 
peer or social worker, (or a combination of these). Eligible studies also included a comparison 
group that either received usual care or a self-management or health intervention with a focus 
other than asthma (placebo).  
 
Selecting and combining outcomes  
 
Information on four primary outcomes, reflective of indicators of good asthma control14, were 
extracted: (i) exacerbations or asthma attacks leading to admission to hospital (hospitalization); 
(ii) asthma symptoms leading to emergency hospital visits; (iii) absence from school; (iv) days of 
restricted activity. Information on a number of secondary outcomes was also extracted and 
synthesized11.  
 A search was conducted on the Cochrane Airways Group Specialised Register, which covers a 
number of databases including CENTRAL, MEDLINE, EMBASE, PsycInfo and CINAHL as 
well as respiratory conference abstracts, for trials, using a strategy outlined in the full review11 
and developed by the Airways Group Trials Search Co-ordinator (details in acknowledgements). 
All results were imported into EPPI-Reviewer 4 (systematic review software16) and screened on 
title and abstract by two reviewers (DK and KH). Full texts were obtained for studies meeting 
initial eligibility criteria and rescreened by both reviewers, who met to discuss and consolidate 
any disagreements. All studies meeting the criteria for study design were included, irrespective 
of the outcomes that were collected. All data were extracted into EPPI-Reviewer 4, which was 
also used for calculating effect sizes including adjustments for clustering16; STATA was used for 
conducting further data transformations and robustness checks17; while RevMan 5.3 was the 
primary software used for combining quantitative data18. All data were initially combined using 
random-effects meta-analyses, as the underlying assumptions of a fixed-effects specification 
were not deemed to be compatible with the likely heterogeneity in intervention types and 
populations across studies.  
 
Adjustments for clustering were made where this was not reported by trialists, and because no 
study included in the meta-analysis provided a direct estimate of the clustering effect through an 
intracluster correlation coefficient (ICC), an estimate of  0.05 was selected based on the ICC 
used in a study not included in the meta-analysis19. We expected outcomes to be reported using 
similar units of analysis, although in reality we encountered a number of variations and used 
Chinn’s formulae20 for converting effect sizes and standard errors between standardized mean 
differences and odds ratios, following direction provided in the Cochrane Handbook21. 
 
We assessed statistical heterogeneity through examining the I2 measure and Cochran’s Q21, and 
explored drivers of heterogeneity through conducting pre-specified sensitivity and subgroup 
analyses. We intended to construct random-effects meta-regression models, which would allow 
us to explore the impact of different covariates simultaneously. However, a relatively low 
number of studies (our largest model included 13 studies) meant that we were unable to extend 
the modelling in this way. We assessed sources of potential bias using the Cochrane 
Collaboration’s Risk of Bias tool22. For publication bias, we plotted the distribution of studies’ 
effect sizes against their standard errors in a funnel plot for each outcome; we also undertook 
formal tests for small-study publication bias using Egger’s test23. However, these tests were 
likely underpowered for at least two of the outcomes (hospitalisations and days of restricted 
activity). Further sensitivity analyses were undertaken on the basis of the study’s risk of bias 
assessment, the impact of using fixed-effects compared to random effects modelling, and the 
impact of studies using a cluster randomised design. 
 
Results 
 
The first search was conducted in April 2015, with updated searches conducted in April 2016 
and 2017. After de-duplication, the titles and abstracts of 379 outcome evaluation studies were 
independently screened by two review authors (KH and DK). Following exclusion on title and 
abstract, the remaining 105 full-text records were assessed for eligibility, and thirty-three 
outcome evaluation studies were included for further analysis (figure 1). 
 
FIGURE 1 – FLOW CHART HERE 
 
The majority of studies (79%) randomised children by school; in contrast just seven studies 
randomised by individuals. The evidence was mainly informed by studies that had taken place in 
North America (24 in the USA and 4 in Canada). Of the remaining, two studies had taken place 
in the UK, two in Australia and one study each in China, Spain and Jordan. Eight studies took 
place in high/senior/secondary schools, three in junior/middle schools, and fifteen in 
primary/elementary schools; a further three studies had taken place in a mixture of schools with 
the remainder being unclear (table 1). School-based asthma interventions took a number of 
diverse forms – from more manualised programmes including the American Lung Association’s 
Open Airways for Schools programme (9 studies), Roaring Adventures of Puff (4 studies), and 
the Triple-A programme (Adolescent Asthma Action; 2 studies) – to other novel intervention 
models being trialled for the first time. A minority of interventions were of relatively low 
intensity, comprising just one session (2 studies) although most were of higher intensity 
comprising three or more sessions (28 studies, with three providing insufficient description). In 
nine studies the interventions were delivered fully or in part by a school or public health nurse or 
nursing student, four involved teachers in delivery, and two studies involved peer delivery (see 
supplementary materials). 
 
Study quality varied according to domain, and for some domains, the risk of bias was deemed to 
be high in studies (see the full review for further details11). However, the overall the potential for 
this risk of bias to compromise the results of the meta-analyses for the primary outcomes was 
deemed to be ‘not serious’ when grading the quality of the evidence and the strength of the 
recommendations.  
 
TABLE 1 HERE - RESULTS 
 
Enough information on exacerbations leading to hospital to calculate an effect size was provided 
by seven studies, six of which were combined in a meta-analysis of standardised mean 
differences (SMD), with all six studies reporting a positive impact of the intervention and little 
evidence of statistical heterogeneity based on I2 (0%) and Cochran’s Q statistics (table 1 and 
figure 2). Overall, the results suggested that school-based asthma self-management interventions 
were moderately effective in reducing levels of hospitalisations among children (SMD -0.19, 
95% CI -0.35 to -0.04). Tests for publication bias were ultimately underpowered, although no 
evidence of publication bias was detected through visual inspection of the data.  
 
A further measure of healthcare usage, emergency department (ED) visits was also included as a 
primary outcome, with data transformed to reflect the differential odds of reports of ED visits 
between intervention and control groups. Based on the results from 13 studies involving 3883 
children, the evidence suggested that school-based asthma self-management interventions were 
effective in reducing the frequency of emergency department visits (ED visits; (OR 0.70, 95% CI 
0.53 to 0.92); figure 3). Among the thirteen included studies, there was substantial heterogeneity 
however, both in terms of magnitude and direction of effect, with three studies having negligible 
effect sizes (close to zero) and two having negative effect sizes; this resulted in an I2 of 26%. The 
number of studies and the level of heterogeneity allowed us to explore potential study 
characteristics that could help to explain the observed variation through planned sub-group 
analyses, although children’s age, school type and socioeconomic status of children did not 
explain the observed heterogeneity. Sensitivity analyses based on model assumptions and data 
transformations did not suggest that the analytical decisions made influenced the effect sizes, and 
although based on a relatively small number of studies, neither the funnel plot nor Egger's test 
were indicative of publication bias. 
 
FIGURE 2 HERE 
FIGURE 3 HERE 
 
Included in our meta-analysis of effects on school absences were 10 studies, although there was 
uncertainty as to whether school-based self-management interventions impacted on reducing 
absences from school (SMD -0.07, 95% CI -0.22 to 0.08). Among the studies, there was very 
high heterogeneity between effect size estimates, with I2 estimated at 70%. Effect sizes from half 
of the studies included in the meta-analysis indicated that the intervention had a negative impact 
in slightly or significantly increasing the number of school absences in the intervention group 
relative to the control. Pre-specified sub-group analyses generally did not suggest that study-
level characteristics explained between study heterogeneity, although one sub-group analysis 
(described in the full Cochrane review11) indicated that studies drawing upon a defined 
theoretical framework were more effective (SMD -0.20, 95% CI -0.36 to -0.04; studies = 6) than 
those that did not (SMD 0.08, 95% CI -0.05 to 0.20; studies = 4); although there remained 
moderate levels of heterogeneity for both sub-groups (figure 4). Sensitivity analyses based on 
model assumptions and data transformations did not suggest that the analytical decisions made 
influenced the effect sizes, and there was negligible evidence of publication bias. 
 
FIGURE 4 
FIGURE 5 
 
Finally, three studies contributed data to our meta-analysis of the impact of school-based asthma 
self-management interventions in reducing the number of days of restricted activity that children 
experienced (Figure 5). These provided evidence that the intervention mode could reduce the 
number of days of restricted activity experienced (SMD -0.30, 95% CI -0.41 to -0.18; studies = 
3), albeit based on a limited number of studies. All three studies provided relatively consistent 
evidence around the direction and magnitude of the effect (I2=0%).  
 
Discussion 
 
The results from the meta-analyses showed that school-based self-management interventions are 
effective in improving healthcare usage including hospitalisations (6 studies) and ED visits (13 
studies) as well as effective in improving an indicator of health status in reducing days of 
restricted activity (3 studies). Effectiveness was not consistent for school absences, where the 
point estimate suggested a small effect and with a confidence interval that crossed the line of no 
effect. 
The intervention appeared most effective for outcomes involving healthcare usage. These were 
measured in a relatively uniform way in studies (although several transformations were made in 
the meta-analyses to facilitate synthesis). The reason why a smaller impact was observed for 
school absences is unclear, although additional subgroup analyses suggested that the way in 
which the intervention was implemented may have a greater impact on this outcome. In 
particular, the reported use of a theoretical framework in the study appeared to distinguish 
between studies that were more effective in reducing levels of school absences compared to 
those that were not. While there is no universal consensus as to the importance of school 
absences as an indicator of asthma control24, demonstrating improvement on this indicator may 
be important in gaining access to school sites and the cooperation of school staff. This result 
does not indicate that use of theory is causal in reducing school absences; however, potential 
explanations might include that where trialists have an in-depth knowledge of how their 
intervention works, which shapes all stages of delivery through to the reporting of the outcomes, 
that this leads to better outcomes for children, particularly for outcomes that may be otherwise 
more intractable; alternatively the reported use of theory may be a marker for the experience of 
the trialists, or trial team.  
There are several limitations to this review. First, most of the studies were conducted in the USA 
and Canada, and very few of the included studies were conducted in the UK, Europe, or beyond. 
Factors reflecting health policy and access to healthcare across different settings are likely to 
influence the design and implementation of an intervention, although their impact was not fully 
assessed here. Nevertheless, the way in which children attend schools is fairly similar worldwide, 
therefore little impact is expected in terms of the applicability of the approach to schools in 
middle and higher income settings. However, the US-focus of studies may impact on the 
transferability of the intervention findings. The nature of healthcare delivery, and the high 
number of children without adequate healthcare coverage could mean that the intervention has a 
greater impact in US settings compared to settings with universal healthcare coverage (e.g. the 
UK), particularly among lower income populations with substantial levels of under-diagnosis 
and low levels of access to the correct medication plans. Several of the trials (e.g.25 26) were 
developed precisely on the basis of this rationale, and selected schools as the delivery site 
because of the universality of education, as opposed to healthcare, in these settings. The 
implications for transferability could mean that lower effect sizes are achieved in settings with 
better healthcare coverage, higher rates of diagnosis, and greater equality in access to appropriate 
medication (e.g. settings such as the UK where healthcare is universally free at the point of 
delivery). Similarly, a greater number of studies were conducted within primary/elementary 
schools than within high/secondary schools. Both the underrepresentation of settings beyond 
North America and high school settings represent caveats to the generalisability of findings. 
A second limitation is that there was variation in the way in which a number of outcomes were 
measured. Previous calls to action have been made to standardise the outcome that are collected 
during children’s asthma trials27-29, although this review suggests that these have only been 
partially successful, given that data from a number of studies that met the eligibility criteria for 
trial design were not included in meta-analysis because the trials did not measure these 
outcomes. While the outcomes included in the meta-analyses were only combined after a lengthy 
consideration of the potential methodological and clinical heterogeneity, there also remains a 
likelihood that at least part of the heterogeneity observed between studies was due to 
measurement error. For many of the secondary outcomes that were examined in the companion 
review11, for example lung function, there was even greater heterogeneity in the measurement of 
outcomes that precluded combining the effect sizes within a meta-analytic framework. In 
addition to greater efforts for standardisation of outcome domains, this review suggests a need 
for greater standardisation of appropriate measurement and reporting of outcomes collected 
within trials. For example, in the case of hospitalisations, the original data were collected in 
studies as the mean number of hospitalisations (continuous count data), reports of any instances 
of hospitalisations (binary data), and median level of hospitalisation (the latter not combined in 
meta-analysis); these also differed in measurement approach (hospitalisations over a relatively 
short duration (e.g. 4 weeks30) compared to a longer exposure period (e.g. 12 months31)). 
Agreement on which outcomes to measure may represent an important first step in standardising 
trial reporting and developing core outcome sets32, however this review suggests that further 
work is needed to agree how these indicators should be operationalised. The diversity of 
measurement approaches, and consequently the number of transformations needed to standardise 
the data into a common metric, do potentially compromise the results. While sensitivity analyses 
were conducted in full to check the robustness of our assumptions, the lack of standardisation 
nevertheless represents a caveat to the results.  
A third limitation is that, since we excluded studies that delivered other asthma interventions, we 
do not know the added value of running an intervention in a school, compared with running an 
intervention in a hospital or community setting. Similarly, we excluded studies that delivered 
asthma interventions in schools, but that did not meet our definition of self-management. This 
may have narrowed our ability to understand the full potential of schools as sites for improving 
children’s asthma. What is clear, however, is that schools provide access to large numbers of 
children with asthma, including those who do not regularly attend appointments with their 
medical provider. 
A fourth limitation is that, while the overall impact of school-based interventions was positive 
for most of the primary outcomes examined in the review, some individual studies did report 
negative intervention impacts among children. For example, in our model of ED visits, two 
studies, both using the same intervention model, reported that children were more likely to 
experience an ED visit after the intervention than the control. The underlying mechanisms of 
how a school-based asthma intervention increases healthcare usage are unclear. Such potentially 
counter-intuitive effects may reflect the content of self-management information delivered to 
children, which could recommended greater contact with healthcare providers when children 
experience asthma exacerbations. A narrative approach to the synthesis of the outcome 
evaluations data including reviewing the content of the self-management education could lead to 
an enhanced understanding of why a small number of trials ostensibly led to more negative 
outcomes among children.  
In summary, this review supports the hypothesis that school-based self-management 
interventions are effective in improving healthcare usage outcomes for children with asthma. 
Although we found no conclusive evidence in the meta-analysis for the impact of the 
intervention on school absences, results from the subgroup analyses suggest that a subgroup of 
studies that explicitly defined their theoretical framework had higher effect sizes. Future 
systematic reviews that can draw on a larger pool of studies may be able to further identify the 
importance of different configurations on the effectiveness of the intervention, and it may be 
possible to use Network Meta-Analyses, drawing on the relatively large number of studies for 
some intervention modes (e.g. Open Airways for Schools), to compare indirectly and directly 
how different intervention approaches perform. Since self-management interventions delivered 
in schools reduce the number of acute episodes of healthcare usage in particular, we conclude 
that the school environment is an important space for delivering interventions aimed at 
improving asthma outcomes in children and young people. 
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 Table 1: Summary of meta-analyses 
Outcome Number 
of 
Studies 
Number of 
Participants 
Effect size 
(modelling strategy) 
Pooled effect size 
and Confidence 
Interval 
I2 
Exacerbations 
leading to 
hospitalisation 
6 1873 Std. Mean 
Difference (IV, 
Random effects, 
95% CI) 
-0.19 [-0.35, -
0.04] 
0% 
Exacerbations 
leading to 
emergency 
department (ED) 
visits 
13 3883 Odds Ratio (IV, 
Random effects, 
95% CI) 
0.70 [0.53, 0.92] 26% 
Absence from school 10 4609 Std. Mean 
Difference (IV, 
Random effects, 
95% CI) 
-0.07 [-0.22, 0.08] 70% 
Days of restricted 
activity 
3 1852 Std. Mean 
Difference (IV, 
-0.30 [-0.41, -
0.18] 
0% 
Random effects, 
95% CI) 
Key: IV: Inverse Variance; CI: Confidence Interval 
 
